Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Vitamin D and Omega-3 Supplementation to Reduce Risk of Metabolic Syndrome

NCT01326442 is registered in ClinicalTrials.gov with University of Guelph as lead sponsor.

NCT NCT01326442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01326442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Vitamin D and Omega-3 Supplementation to Reduce Risk of Metabolic Syndrome
Lead sponsor
University of Guelph
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
December 31, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia, hypertension, obesity, type 2 diabetes mellitus